Long-Term Outcomes and Prognostic Factors of High-Risk Malignant Melanoma Patients after Surgery and Adjuvant High-Dose Interferon Treatment: A Single-Center Experience

Publisher： Karger

E-ISSN： 1421-9794|60|4|228-238

ISSN： 0009-3157

Source： Chemotherapy, Vol.60, Iss.4, 2015-04, pp. : 228-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence, Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery: Experience with 344 Consecutive Patients at a Single Tertiary Center

By Barber Sean M.   Liebelt Brandon D.   Baskin David S.  

Journal of Clinical Medicine, Vol. 3, Iss. 4, 2014-10 ,pp. : 1199-1219

MDPI

Access to resources Recommend Favorite

High-Dose Platinum Combination Therapy in Pretreated Patients with Disseminated Melanoma

By  

Chemotherapy, Vol. 53, Iss. 6, 2007-10 ,pp. : 422-428

Karger

Access to resources Recommend Favorite

Pre-Treatment Serum C-Reactive Protein Level Is An Independent Risk Factor for Development of Nephrotoxicity in Patients Receiving High-Dose Vancomycin

By  

Pharmacology, Vol. 97, Iss. 5-6, 2016-02 ,pp. : 294-300

Karger

Access to resources Recommend Favorite

A Phase I Study of High-Dose Calcitriol in Combination with Temozolomide for Patients with Metastatic Melanoma

By Pettijohn Erin   Martone Brenda   Rademaker Alfred   Kuzel Timothy  

Journal of Personalized Medicine, Vol. 4, Iss. 4, 2014-10 ,pp. : 448-458

MDPI

Access to resources Recommend Favorite

Optimal Treatment Strategies for Acute Exacerbations of Chronic Bronchitis: High-Risk Patients

By  

Chemotherapy, Vol. 47, Iss. 4, 2001-09 ,pp. : 47-52

Karger

Access to resources Recommend Favorite